STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
268
13F, latest reported quarter
What the filings say about PL
Insiders, 180 days
-$14.1M net sold
6 sellers · 38% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-03-27
Planned sales (Form 144), 90 days
$2.6M
5 notices
Planet Labs PBC insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Planet Labs PBC insiders sold a net $14.1M of stock across 48 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Jul 15, 2026.
The trade is 21.9% of the 182,897 shares held after it.
4 other insiders sold within 30 days.
268 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Robinson Kristen sold about $565.6K of PL under a 10b5-1 plan on Oct 15, 2026; 4 other insiders sold within 30 days and 268 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Jul 13, 2026.
The trade is 21.2% of the 30,620 shares held after it.
4 other insiders sold within 30 days.
268 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Raymond John w sold about $98.9K of PL under a 10b5-1 plan on Oct 13, 2026; 4 other insiders sold within 30 days and 268 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Jul 1, 2026.
The trade is 4.6% of the 250,373 shares held after it.
4 other insiders sold within 30 days.
268 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Brennan Ita M sold about $187.5K of PL under a 10b5-1 plan on Oct 1, 2026; 4 other insiders sold within 30 days and 268 funds added in the latest 13F quarter.
5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Jul 10, 2026.
The trade is 30.7% of the 170,171 shares held after it.
4 other insiders sold within 30 days.
268 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Co-Founder Chief Strategy Off. Schingler Robert H sold about $886.2K of PL under a 10b5-1 plan on Sep 17, 2026; 4 other insiders sold within 30 days and 268 funds added in the latest 13F quarter.
20 earlier Form 4 trades (code P or S) here by this insider (20 sales), the last on Jul 23, 2026.
The trade is 9.6% of the 577,915 shares held after it.
4 other insiders sold within 30 days.
268 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President & CFO Johnson Ashley F. sold about $944.3K of PL under a 10b5-1 plan on Sep 17, 2026; 4 other insiders sold within 30 days and 268 funds added in the latest 13F quarter.
48 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
PL planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
THE GARY AND KRISTEN ROBINSON TRUST
Filed 2026-10-15
$565.2K
Raymond Family Rev Trust U/A DTD 05/30/2023
Filed 2026-10-13
$103.6K
ITA BRENNAN
Filed 2026-10-01
$188.5K
Johnson Joint Revocable Trust
Filed 2026-09-17
$891.7K
ULYSSES TRUST 02021.1 U/ADTD 02/26/2021
Filed 2026-09-17
$836.9K
PL mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Global X Space Tech ETF
$8.8M position · as of 2026-05-31
11.9%
Tema Space Innovators ETF
$173.8M position · as of 2026-05-31
6.7%
VanEck Space ETF
$3.2M position · as of 2026-06-30
5.4%
Roundhill Space & Technology ETF
$3.8M position · as of 2026-06-30
5.1%
Procure Space ETF
$21.8M position · as of 2026-07-31
3.7%
State Street(R) SPDR(R) S&P Kensho Final Frontiers ETF
$8.2M position · as of 2026-06-30
3.3%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$4.6M
$58.3M
$2.1M
+131%
+87%
2024
$4.7M
$14.1M
$2.0M
-44%
+44%
2023
$6.3M
-$38.6K
$2.8M
-79%
+10%
2022
$610.3K
-$351.8K
$1.0M
-54%
-26%
2021
$10.9M
$6.9M
$12.3M
-44%
-6%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $14.1M sold by insiders over 180 days, 268 funds added last quarter, $2.6M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$378.3M
four quarters, 2025-08-01 to 2026-07-31
Revenue, TTM PL
FY Jan 2026
$307.7M
FY Jan 2025
$244.4M
FY Jan 2024
$220.7M
FY Jan 2023
$191.3M
FY Jan 2022
$131.2M
Jul 2026
$116.1M
Apr 2026
$94.2M
Jan 2026
$86.8M
Oct 2025
$81.3M
Jul 2025
$73.4M
Apr 2025
$66.3M
Jan 2025
$61.6M
Oct 2024
$61.3M
At each fiscal year end
Single quarter
Net margin, TTM
-95.1%
net income over revenue, 2025-08-01 to 2026-07-31
Net margin, TTM PL
FY Jan 2026
-80.2%
FY Jan 2025
-50.4%
FY Jan 2024
-63.7%
FY Jan 2023
-84.7%
FY Jan 2022
n/a
Jul 2026
-8.1%
Apr 2026
-147.5%
Jan 2026
-175.6%
Oct 2025
-72.8%
Jul 2025
-30.8%
Apr 2025
-19.1%
Jan 2025
-57.1%
Oct 2024
-32.8%
At each fiscal year end
Single quarter
Free cash flow, TTM
$24.7M
operating cash flow minus capex, 2025-08-01 to 2026-07-31
Free cash flow, TTM PL
FY Jan 2026
$57.6M
FY Jan 2025
-$58.7M
FY Jan 2024
-$88.7M
FY Jan 2023
-$84.4M
FY Jan 2022
n/a
Jul 2026
$25.6M
Apr 2026
-$1.9M
Jan 2026
-$951.0K
Oct 2025
$1.9M
Jul 2025
$47.5M
Apr 2025
$9.2M
Jan 2025
-$17.9M
Oct 2024
-$3.6M
At each fiscal year end
Single quarter
Debt to equity
0.00x
long-term debt only, 2022-01-31 (54 months older than the period end); equity 2026-07-31
Debt to equity PL
FY Jan 2026
0.00x
FY Jan 2025
0.00x
FY Jan 2024
0.00x
FY Jan 2023
0.00x
FY Jan 2022
0.00x
Jul 2026
0.00x
Apr 2026
0.00x
Jan 2026
0.00x
Oct 2025
0.00x
Jul 2025
0.00x
Apr 2025
0.00x
Jan 2025
0.00x
Oct 2024
0.00x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt to cover
Cash flow to debt PL
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-72.0%
TTM net income over average of 2025-07-31 and 2026-07-31
Return on equity PL
FY Jan 2026
-78.4%
FY Jan 2025
-25.7%
FY Jan 2024
-25.7%
FY Jan 2023
-26.5%
FY Jan 2022
n/a
Jul 2026
-72.0%
Apr 2026
-84.0%
Jan 2026
-78.4%
Oct 2025
-31.8%
Jul 2025
-19.9%
Apr 2025
-22.5%
Jan 2025
-25.7%
Oct 2024
-23.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-33.8%
TTM net income over average of 2025-07-31 and 2026-07-31
Return on assets PL
FY Jan 2026
-27.7%
FY Jan 2025
-18.4%
FY Jan 2024
-19.3%
FY Jan 2023
-20.6%
FY Jan 2022
n/a
Jul 2026
-33.8%
Apr 2026
-39.1%
Jan 2026
-27.7%
Oct 2025
-14.9%
Jul 2025
-13.4%
Apr 2025
-16.0%
Jan 2025
-18.4%
Oct 2024
-17.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital PL
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-13.1%
operating income (EBIT proxy) over average of 2025-07-31 and 2026-07-31 minus current liabilities
Return on capital employed PL
FY Jan 2026
-16.3%
FY Jan 2025
-22.0%
FY Jan 2024
-28.4%
FY Jan 2023
-26.6%
FY Jan 2022
n/a
Jul 2026
-13.1%
Apr 2026
-14.8%
Jan 2026
-16.3%
Oct 2025
-11.1%
Jul 2025
-16.4%
Apr 2025
-19.8%
Jan 2025
-22.0%
Oct 2024
-24.1%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing PL
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value PL
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield PL
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing PL
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
PL ranks highest on financial health (99th percentile) and institutional and government (78th), and lowest on insider conviction (13th), among Tech Hardware peers.
Profitability
21
Inputs
Return on equity-72.0% · 14 pct, sector of 77
Return on assets-33.8% · 21 pct, sector of 92
Return on invested capitalpre-tax loss, no effective tax rate to apply
Return on capital employed-13.1% · 27 pct, sector of 72
Financial health
100
Inputs
Debt to equity0.00x · 100 pct, sector of 72
Cash flow to debtno debt to cover
Growth
70
Inputs
Revenue growth, YoY+25.9% · 76 pct, sector of 102
Backlog growth, YoY+9.1% · 64 pct, sector of 48
Insider conviction
13
Inputs
Net Form 4 buying (codes P and S), 180d-$11.4M · 26 pct, sector of 75
Insider buyers, 180d0 · 0 pct, sector of 77
Institutional and government
78
Inputs
Funds adding, latest quarter268 · 74 pct, sector of 89
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$2.1M · 83 pct, universe of 1,063
Risk and compliance
30
Inputs
Short interest, % of float+11.0% · 26 pct, sector of 105
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+16.9% · 34 pct, sector of 80
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
PL filings, in plain words
Are Planet Labs PBC insiders buying or selling PL?
In the 180 days to 2026-10-27, Planet Labs PBC insiders were net sellers, a net $14.1M across purchases and sales reported on Form 4, by 6 sellers.
Have members of Congress traded PL?
Yes, but not in the year to 2026-10-27; the latest on record is a sale by George Whitesides dated 2025-03-27.
Are there planned insider sales of PL?
Yes. 5 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $2.6M of stock; the latest, by THE GARY AND KRISTEN ROBINSON TRUST, was filed 2026-10-15.
Read the full summary
In the 180 days to 2026-10-27, Planet Labs PBC insiders were net sellers of PL, a net $14.1M across purchases and sales reported on Form 4 by 6 sellers. 38% of the 13 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Members of Congress have disclosed trades in PL, none in the last year; the latest on record is a sale by George Whitesides dated 2025-03-27. Insiders filed 5 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $2.6M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.